1. Introduction

   • Louis Lasagna

   Introduction 15 October 2012 Pages: 1 - 2

2. US Economic Revolution

   • Regina Herzlinger

   Current Opinion 15 October 2012 Pages: 3 - 6

3. The Patient Rights Movement in Europe

   • Albert van der Zeijden

   Current Opinion 15 October 2012 Pages: 7 - 13

4. Post-Modern Drug Evaluation

   • Jerry Avorn

   Current Opinion 15 October 2012 Pages: 15 - 20

5. The Distribution of Sales Revenues from Pharmaceutical Innovation

   • Henry G. Grabowski
   • John Vernon

   Original Research Article 15 October 2012 Pages: 21 - 32

   

6. Is There a Link Between Pharmaceutical Consumption and Improved Health in OECD Countries?

   • Richard D. Miller Jr
   • H. E. Frech III

   Original Research Article 15 October 2012 Pages: 33 - 45

   

7. The Increasing Necessity for Market-Based Pharmaceutical Prices

   • John E. Calfee

   Review Article 15 October 2012 Pages: 47 - 57

8. Reimbursement for New Health Technologies

   • Dermot Glynn

   Current Opinion 15 October 2012 Pages: 59 - 67

   

9. Restructuring French Hospitals

   • Alain Sommer

   Current Opinion 15 October 2012 Pages: 69 - 76

   

10. Consumer Empowerment as a Solution to Health System Financing

    • Wilfried Prewo

    Current Opinion 15 October 2012 Pages: 77 - 83

11. Healthcare Systems

    • Paul Belien

    Current Opinion 15 October 2012 Pages: 85 - 93

12. Payment Systems and Considerations of Case Mix — Are Diagnosis-Related Groups Applicable in Japan?

    • Koichi Kawabuchi

    Original Research Article 15 October 2012 Pages: 95 - 110

    

13. Concluding Remarks

    • Louis Lasagna

    Concluding Remarks 15 October 2012 Pages: 111 - 112